Profusa, Inc.

Profusa, Inc. (ticker: PFSA) is a medical technology company focused on implantable continuous biosensing, developing tissue-integrated sensors designed for real-time physiological monitoring across clinical and defense health applications. The company operates in the digital health and medical device sector, with its platform enabling oxygen and metabolite tracking through minimally invasive subcutaneous implants. Profusa filed a Form 10-Q with the SEC on August 11, 2022, under accession number 0001213900-22-046847, reflecting its status as a reporting public company at that time. To access full filing history, deal timelines, and data analytics for Profusa and hundreds of other SPAC-linked companies, sign up for a SpacDesk account at spacdesk.com.